MEDEXPORT LONDON LTD

Executive Summary

MEDEXPORT LONDON LTD appears financially stable with strong liquidity and positive net assets growth since incorporation in 2021. The company maintains good compliance with filing deadlines and operates within a small company regime. However, its short operating history and concentration of control warrant further investigation into governance and operational sustainability before investment.

MEDEXPORT LONDON LTD - Analysis Report

Company Number: 13548176

Analysis Date: 2025-07-29 19:11 UTC

1. Risk Rating: LOW
   MEDEXPORT LONDON LTD demonstrates strong liquidity with cash holdings significantly exceeding current liabilities, positive net current assets, and growing net assets year on year. There are no overdue filings or regulatory flags, supporting a low-risk assessment.

2. Key Concerns:

• Dependence on a single ultimate controlling party (Mr Khaled Ali Muhieddine) and a corporate director based abroad may present governance or operational concentration risks.
• The company is newly incorporated (2021) with limited operating history, so long-term operational stability is not yet proven.
• Absence of audited financial statements limits insight into the accuracy and completeness of reported figures.

3. Positive Indicators:

• Healthy liquidity position with cash of £157k against current liabilities of £22.8k as of August 2024.
• Consistent growth in net assets from £76.9k in 2021 to £144.3k in 2024, indicating retained earnings accumulation.
• No overdue accounts or confirmation statements, reflecting compliance with filing requirements.
• Small company exemption used appropriately, indicating adherence to regulatory thresholds.

4. Due Diligence Notes:

• Verify the nature and stability of revenue streams and client base, given the SIC codes cover motor vehicle maintenance and electric motor manufacturing, which are distinct sectors.
• Investigate the director and corporate director’s roles and decision-making processes to assess governance robustness and potential related party transactions.
• Confirm absence of contingent liabilities or off-balance-sheet obligations not disclosed in the unaudited accounts.
• Review the director’s loan account movements and any related party balances for potential financial exposure.
• Assess whether the company has sufficient operational scale and contracts to sustain growth beyond initial years.